CHRS
Price
$1.21
Change
+$0.03 (+2.54%)
Updated
Sep 30 closing price
Capitalization
176.13M
40 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$0.28
Change
-$0.04 (-12.50%)
Updated
Sep 30 closing price
Capitalization
1.38M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CHRS vs SLXN

CHRS vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CHRS vs. SLXN commentary
Oct 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHRS is a Buy and SLXN is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CHRS: Fundamental Ratings
CHRS
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CHRSSLXN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 1 day ago
51%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
43%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 3 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 10 days ago
56%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 1 day ago
28%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
83%
COMPARISON
Comparison
Oct 01, 2026
Stock price -- (CHRS: $1.21 vs. SLXN: $0.28)
Brand notoriety: CHRS and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CHRS: 92% vs. SLXN: 116%
Market capitalization -- CHRS: $176.13M vs. SLXN: $1.38M
CHRS [@Biotechnology] is valued at $176.13M. SLXN’s [@Biotechnology] market capitalization is $1.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHRS’s FA Score shows that 0 FA rating(s) are green while SLXN’s FA Score has 0 green FA rating(s).

  • CHRS’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, CHRS is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHRS’s TA Score shows that 3 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • CHRS’s TA Score: 3 bullish, 5 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than CHRS.

Price Growth

CHRS (@Biotechnology) experienced а -3.97% price change this week, while SLXN (@Biotechnology) price change was -12.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.67%. For the same industry, the average monthly price growth was -10.91%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

CHRS is expected to report earnings on Nov 09, 2026.

SLXN is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CHRS
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM13.421.92
+16.70%
Contineum Therapeutics
OPEN2.37N/A
N/A
Opendoor Technologies
THRY1.57-0.02
-1.26%
Thryv Holdings
TRU61.12-3.17
-4.93%
TransUnion
ZNB1.16-0.09
-7.20%
Zeta Network Group

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with ARRY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
+2.54%
ARRY - CHRS
39%
Loosely correlated
+1.00%
AXON - CHRS
38%
Loosely correlated
+0.70%
LCTX - CHRS
36%
Loosely correlated
+0.87%
AMRN - CHRS
35%
Loosely correlated
-1.07%
VIR - CHRS
33%
Loosely correlated
+4.98%
More